Biotechnology (15) | Cooperation Agreements (15)

Browse by Company

Adverum Biotechnologies, Inc. (1 contract)
ARCA biopharma, Inc. (1)
ATHERSYS, INC (2)
CATALYST BIOSCIENCES, INC. (1)
CYTRX CORP (2)
Dermavant Sciences Ltd (1)
Eagle Pharmaceuticals, Inc. (1)
Health Sciences Acquisitions Corp (1)
Myovant Sciences Ltd. (1)
ORGANOVO HOLDINGS, INC. (1)
PDL BIOPHARMA, INC. (1)
PharmaCyte Biotech, Inc. (1)
TYME TECHNOLOGIES, INC. (1)

Recent Contracts

Form of Cooperation Agreement, dated as of September 2, 2022, by and between Tyme Technologies, Inc. and each of its current executive officers (TYME TECHNOLOGIES, INC., Filed With SEC on September 6, 2022)
Cooperation Agreement dated August 15, 2022, by and between PharmaCyte Biotech, Inc. and Iroquois Master Fund Ltd. and its affiliates (PharmaCyte Biotech, Inc., Filed With SEC on August 16, 2022)
Cooperation Agreement, dated as of June 15, 2022, by and among ARCA biopharma, Inc., Cable Car Capital LLC, the Funicular Fund LP, Funicular Funds, LP and Jacob Ma-Weaver (ARCA biopharma, Inc., Filed With SEC on June 21, 2022)
Co-operation Agreement, dated March 27, 2022, by and between Eagle Pharmaceuticals, Inc. and Acacia Pharma Group plc (Eagle Pharmaceuticals, Inc., Filed With SEC on March 28, 2022)
Amendment to Cooperation Agreement, dated as of August 5, 2021, by and among Athersys, Inc. and HEALIOS K.K. and Dr. Tadahisa Kagimoto (ATHERSYS, INC, Filed With SEC on November 15, 2021)
Amendment No. 1 to the Cooperation Agreement, dated September 2, 2021, by and between CytRx Corporation and Jerald A. Hammann (CYTRX CORP, Filed With SEC on September 9, 2021)
Cooperation Agreement, dated as of February 16, 2021, by and among Athersys, Inc. and HEALIOS K.K. and Dr. Tadahisa Kagimoto (ATHERSYS, INC, Filed With SEC on February 16, 2021)
Cooperation Agreement, dated August 21, 2020, by and between CytRx Corporation and Jerald A. Hammann (CYTRX CORP, Filed With SEC on August 24, 2020)
Cooperation Agreement, dated July 14, 2020, between the Company and Keith Murphy (ORGANOVO HOLDINGS, INC., Filed With SEC on July 15, 2020)
Cooperation and Support Agreement, dated as of February 27, 2020, by and among PDL BioPharma, Inc., Engine Capital, L.P. and its affiliates (PDL BIOPHARMA, INC., Filed With SEC on February 28, 2020)